Zhenguang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhenguang Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Zhao
Department of Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication - Hongwei Xue
Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication - Qinqin Wang
Department of Ultrasound, The Affiliated Hospital of Qingdao University, China
1 shared publication Tao Wang
Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266100, China
1 shared publication- Wenbin Jiang
Department of Health Management Center, The Affiliated Hospital of Qingdao University, Qingdao, China -
1 shared publication - Xiaojuan Zhang
Department of Ultrasound, The Affiliated Hospital of Qingdao University, China
1 shared publication
Latest Publications
- Open Access
- 20 March 2019
- Vol. 22 (3) , 167-172
[Application of Metabolic Parameters Measured by ¹⁸F-FDG PET/CT in the Evaluation of the Prognosis of Non-small Cell Lung Cancer].
Tumor-node-metastasis (TNM) staging system is the most important basis for making therapeutic decisions and predicting prognosis of lung cancer patients. The metabolic parameters including standardized uptake value (SUV), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) measured by ¹⁸F-fluorodeoxyglucose-positron emission tomography (¹⁸F-FDG PET/CT) associate with tumor aggressiveness and can provide additional prognostic information. A new staging methodology combines the conventional cTNM with the metabolic tumor burden quantified from the PET images is a better predictor of overall survival with superior stratifying power may help oncologists to make better treatment plans. ¹⁸F-FDG PET/CT image texture analysis, as an emerging research tool, is used to quantify the spatial heterogeneity of radioactive uptake in tumors, thereby to explore the biological characteristics of the tumor. This article reviews developments in evaluating the ¹⁸F-FDG PET/CT metabolic parameters and its role as a prognostic factor for non-small cell lung cancer. .
- 20 March 2019
- Vol. 22 (3) , 167-172
Open Access[Application of Metabolic Parameters Measured by ¹⁸F-FDG PET/CT in the Evaluation of the Prognosis of Non-small Cell Lung Cancer].
Tumor-node-metastasis (TNM) staging system is the most important basis for making therapeutic decisions and predicting prognosis of lung cancer patients. The metabolic parameters including standardized uptake value (SUV), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) measured by ¹⁸F-fluorodeoxyglucose-positron emission tomography (¹⁸F-FDG PET/CT) associate with tumor aggressiveness and can provide additional prognostic information. A new staging methodology combines the conventional cTNM with the metabolic tumor burden quantified from the PET images is a better predictor of overall survival with superior stratifying power may help oncologists to make better treatment plans. ¹⁸F-FDG PET/CT image texture analysis, as an emerging research tool, is used to quantify the spatial heterogeneity of radioactive uptake in tumors, thereby to explore the biological characteristics of the tumor. This article reviews developments in evaluating the ¹⁸F-FDG PET/CT metabolic parameters and its role as a prognostic factor for non-small cell lung cancer. .
- 1 February 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 99, 88-93
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma
- 1 February 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 99, 88-93
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma